Why Are Generic Drugs Being Held Up in Transit? Intellectual Property Rights, International Trade, and the Right to Health in Brazil and Beyond
Journal of Law, Medicine and Ethics 40 (2):197-205 (2012)
| Abstract | Access to medicines faces a new legal threat: “border enforcement” of drug patents. Using Brazil as an example, this article shows how the right to health depends on international trade. Border seizures of generic drugs present human rights and trade institutions with a unique challenge. Can public health advocates rise to meet it? | |||||||||
| Keywords | No keywords specified (fix it) | |||||||||
| Categories | ||||||||||
| Options |
|
|||||||||
Download options| PhilPapers Archive |
Upload a copy of this paper Check publisher's policy on self-archival Papers currently archived: 5,875 |
| External links |
 |
| Through your library | Configure |
Similar books and articlesRudolf V. van Puymbroeck (2010). Basic Survival Needs and Access to Medicines – Coming to Grips with TRIPS: Conversion + Calculation. Journal of Law, Medicine and Ethics 38 (3):520-549.
Joseph Millum (2008). Are Pharmaceutical Patents Protected by Human Rights? Journal of Medical Ethics 34 (11):e25-e25.
Michael Gorman (2005). Intellectual Property Rights, Moral Imagination, and Access to Life-Enhancing Drugs. Business Ethics Quarterly 15 (4):595-613.
Scott Wisor (2012). Property Rights and the Resource Curse: A Reply to Wenar. Journal of Philosophical Research 37:185-204.
Jonathan Liberman (2012). Combating Counterfeit Medicines and Illicit Trade in Tobacco Products: Minefields in Global Health Governance. Journal of Law, Medicine and Ethics 40 (2):326-347.
Meri Koivusalo (2010). Common Health Policy Interests and the Shaping of Global Pharmaceutical Policies. Ethics and International Affairs 24 (4):395-414.
Lisa Forman (2007). Trade Rules, Intellectual Property, and the Right to Health. Ethics and International Affairs 21 (3):337–357.
Patricia J. Arnold & Terrie C. Reeves (2006). International Trade and Health Policy: Implications of the GATS for US Healthcare Reform. Journal of Business Ethics 63 (4):313 - 332.
Daniel Wei L. Wang & Octavio Luiz Motta Ferraz (2012). Pharmaceutical Companies Vs. The State: Who Is Responsible for Post-Trial Provision of Drugs in Brazil? Journal of Law, Medicine and Ethics 40 (2):188-196.
Analytics
Monthly downloads |
Added to index2012-07-13Total downloads4 ( #180,507 of 556,898 )Recent downloads (6 months)1 ( #64,931 of 556,898 )How can I increase my downloads? |
My notes
Discussion
